Yan Zhang
15Patents
4h-index
47Co-inventors
60Inventor score
Filing activity: May 31, 1995 → Jul 21, 2022
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8343747B2 | Amylases and glucoamylases, nucleic acids encoding them and methods for making and using them | Emerging Cross-Sectional Technologies | 27 | Active |
| US10377827B2 | Antigen binding proteins that bind c-met | Chemistry; Metallurgy | 14 | Active |
| US5876949A | Antibodies specific for fragile X related proteins and method of using the same | Chemistry; Metallurgy | 13 | Expired |
| US7323178B1 | Method of identification of equine herpes virus type 1 causing neurological disease, method of producing a vaccine against neurological disease caused by equine herpes virus type 1, and vaccine against neurological disease caused by equine herpes virus type 1 | Chemistry; Metallurgy | 12 | Expired |
| US10100299B2 | Amylases and glucoamylases, nucleic acids encoding them and methods for making and using them | Emerging Cross-Sectional Technologies | 2 | Active |
| US11453864B2 | DNase H activity of Neisseria meningitidis Cas9 | Chemistry; Metallurgy | 1 | Active |
| US8124841B2 | Truncation of the C-terminal end of alpha-amylase | Chemistry; Metallurgy | 0 | Active |
| US10883098B2 | Amylases and glucoamylases, nucleic acids encoding them and methods for making and using them | Emerging Cross-Sectional Technologies | 0 | Active |
| US12145993B2 | Sequence of antibody heavy chain constant region for enhancing agonistic antibody activity | Chemistry; Metallurgy | 0 | Active |
| US12129299B2 | Mutant anti-CTLA-4 antibodies with improved immunotherapeutic effect but attenuated adverse effects | Chemistry; Metallurgy | 0 | Active |
| US11155628B2 | Antigen binding proteins that bind c-Met | Chemistry; Metallurgy | 0 | Active |
| US11739312B2 | Amylases and glucoamylases, nucleic acids encoding them and methods for making and using them | Emerging Cross-Sectional Technologies | 0 | Active |
| US12104183B2 | DNase H activity of Neisseria meningitidis Cas9 | Chemistry; Metallurgy | 0 | Active |
| US9429581B2 | IP-10 antibody dosage escalation regimens | Chemistry; Metallurgy | 0 | Active |
| US12044675B2 | Genetically encoded calcium indicators (GECIs) and methods of making and using | Physics | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.